Profil TRB Chemedica SA in Vouvry

Beschreibung und Mehrwerte zu TRB Chemedica SA

Pharmaunternehmen, Impfstoffe, Arzneimittel

TRB CHEMEDICA is a family owned, multinational pharmaceutical group headquartered in Vouvry, Switzerland. The Group has more than 20 years experience in the development and marketing of pharmaceutical products and is involved in research and development, manufacturing, registration, marketing and licensing. The therapeutic focus of the Group is rheumatology, ophthalmology and neurology.

TRB CHEMEDICA currently markets 15 products, both ethical pharmaceuticals and medical devices, that are licensed and sold in more than 40 countries worldwide. In addition to a number of innovative pharmaceutical compounds in key market segments, the Group has a long experience and a particular specialisation in patented products based on sodium hyaluronate. The commitment to innovation is seen in the significant product pipeline that will help to fuel growth in each of the targeted therapeutic areas as well as introduce the group into new areas of therapeutic focus.

Manufacturing activities include the production of pharmaceutical raw materials, pharmaceutical finished products and medical devices. The manufacturing facilities of the Group are based in Vouvry, Switzerland and Buenos Aires, Argentina.

TRB CHEMEDICA is committed to growth in the international arena and today employs more than 500 people worldwide with its own sales operations in Argentina, Austria, Benelux, Brazil, France, Germany, Hong Kong, Malaysia, Mexico, Switzerland, Thailand and United Kingdom.